New Delhi: The coronavirus cases in India surpassed 49,000 mark after the country registered 49,391 cases. In the last 24 hours, 2,958 new cases and 126 deaths were reported.
Meanwhile Prime Minister Narendra Modi took a detailed review of the current status of India’s efforts in vaccine development, drug discovery, diagnosis and testing. Indian vaccine companies are well known for their quality, manufacturing capacity and global presence.
Over 30 Indian vaccines are in different stages of corona vaccine development, with a few going on to the trial stages.
In diagnosis and testing, several academic research institutions and start-ups have developed new tests, both for the RT-PCR approach and for the antibody detection. In addition, by linking laboratories all over the country, capacity for both these kinds of tests have been enormously scaled up.
